Trial to evaluate comparable efficacy of a 1-L PEG and ascorbic acid with sennoside versus a 2-L PEG and ascorbic acid for bowel preparatio
Not Applicable
- Conditions
- colonoscopyD003113patients who require colonoscopy
- Registration Number
- JPRN-jRCT1051220043
- Lead Sponsor
- Fukuda Takashi
- Brief Summary
The 1L-PEG/AS regimen was comparable to the 2L-PEG/A regimen in terms of BP adequacy, requiring lesser BP solution volumes, with better patient tolerance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 344
Inclusion Criteria
1) patients who were scheduled for elective colonoscopy
2) patients who aged over 20 years old and under 85 years old
3) patients who were able to fill in the informed consent form for participation
Exclusion Criteria
1) severe heart failure (NYHA class III or IV)
2) severe hepatic failure (Child-Pugh C)
3) active inflammatory bowel disease
4) dementia
5) allergy to Moviprep or sennoside
6) advanced colorectal cancer
7) intestinal resection
8) past history of participance in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method inadequate bowel preparation rate scored by Boston Bowel Preparation Scale (BBPS)
- Secondary Outcome Measures
Name Time Method procedure-related parameters, safety and tolerability